Patent №
US 8,901,110
Granted
2014-12-02
Filed 2013
Owner
CELGENE CORPORATION
+1 more
Lab
—
AI components
1
evo
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
13740012
Provided herein are biomarkers for hepatocellular carcinoma and uses thereof.
AI classification
Evolutionary computation0.50
Vision0.04
Natural language0.02
Machine learning0.01
Knowledge representation0.00
Planning0.00
Speech0.00
AI hardware0.00
Ownership
CELGENE CORPORATION
assignment · 353420890
RHODE ISLAND HOSPITAL, A LIFESPAN PARTNER
assignment · 353420890
Assignors
WANDS, JACK R., KIM, MIRAN
On an employer assignment, the assignors are typically the inventors.
From the same owner
METHODS OF CLASSIFYING DIFFUSE LARGE B-CELL LYMPHOMAUS 12,400,737 · 2025Digital Health Prognostic Analyzer for Multiple Myeloma Mortality PredictionsUS 11,626,210 · 2023ANIMAL AND HUMAN ANTI-TRYPANOSOMONAL AND ANTI-LEISHMANIA AGENTSUS 10,010,555 · 2018MODULATION OF STEM AND PROGENITOR CELL DIFFERENTIATION, ASSAYS, AND USES THEREOFUS 7,498,171 · 2009METHODS FOR DELIVERING A DRUG TO A PATIENT WHILE PREVENTING THE EXPOSURE OF A FOETUS OR OTHER CONTRAINDICATED INDIVIDUAL TO THE DRUGUS 6,767,326 · 2004METHODS FOR DELIVERING A DRUG TO A PATIENT WHILE RESTRICTING ACCESS TO THE DRUG BY PATIENTS FOR WHOM THE DRUG MAY BE CONTRAINDICATEDUS 6,755,784 · 2004METHODS FOR DELIVERING A DRUG TO A PATIENT WHILE RESTRICTING ACCESS TO THE DRUG BY PATIENTS FOR WHOM THE DRUG MAY BE CONTRAINDICATEDUS 6,561,977 · 2003Methods for delivering a drug to a patient while avoiding the occurrence of an adverse side effect known or suspected of being caused by the drugUS 6,315,720 · 2001